Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
February 14, 2025
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer's disease
Sarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
A Cascade of Care for Alcohol Use Disorder: Using 2015-2018 National Survey on Drug Use and Health Data to Identify Gaps in Care
Carrie M Mintz, Sarah M Hartz, Sherri L Fisher, et al.
BMJ Open
|
January 7, 2026
What is the psychological and cognitive impact of returning Alzheimer disease dementia research results to healthy research participants? a delayed-start randomised clinical trial protocol for the WeSHARE study (Washington University study of having Alzheimer disease <b>r</b>esearch results explained)
Sarah M Hartz, Spondita Goswami, Amy Oliver, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer disease
Sarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.
Alcoholism, Clinical and Experimental Research
|
May 16, 2021
A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care
Carrie M Mintz, Sarah M Hartz, Sherri L Fisher, et al.
Frontiers in Genetics
|
August 31, 2016
Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
Caitlin E Carey, Arpana Agrawal, Kathleen K Bucholz, et al.
BMJ Open
|
June 25, 2026
Strategies to increase medications for opioid use disorder in hospital settings in the USA: protocol for a scoping review
Benjamin Hoemann, Alex Lane, Randy O Laine, et al.
Alcohol, Clinical & Experimental Research
|
April 6, 2026
The relationship between alcohol use disorder, measures of cognitive decline, and Alzheimer disease biomarkers in middle aged and older adults
Lisa A Hayibor, Andrey Anokhin, Sherri L Fisher, et al.
Journal of Clinical Psychopharmacology
|
December 21, 2020
Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression
Tahir Rahman, Cory Patrick, Cynthia Ma, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 18, 2024
Hippocampal volumes in UK Biobank are associated with <i>APOE</i> only in older adults
Ariya Chaloemtoem, Vera Thornton, Yoonhoo Chang, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Alzheimer'S & Dementia (New York, N. Y.)
|
February 14, 2025
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer's disease
Sarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
A Cascade of Care for Alcohol Use Disorder: Using 2015-2018 National Survey on Drug Use and Health Data to Identify Gaps in Care
Carrie M Mintz, Sarah M Hartz, Sherri L Fisher, et al.
BMJ Open
|
January 7, 2026
What is the psychological and cognitive impact of returning Alzheimer disease dementia research results to healthy research participants? a delayed-start randomised clinical trial protocol for the WeSHARE study (Washington University study of having Alzheimer disease <b>r</b>esearch results explained)
Sarah M Hartz, Spondita Goswami, Amy Oliver, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer disease
Sarah M Hartz, Suzanne E Schindler, Marissa L Streitz, et al.
Alcoholism, Clinical and Experimental Research
|
May 16, 2021
A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care
Carrie M Mintz, Sarah M Hartz, Sherri L Fisher, et al.
Frontiers in Genetics
|
August 31, 2016
Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
Caitlin E Carey, Arpana Agrawal, Kathleen K Bucholz, et al.
BMJ Open
|
June 25, 2026
Strategies to increase medications for opioid use disorder in hospital settings in the USA: protocol for a scoping review
Benjamin Hoemann, Alex Lane, Randy O Laine, et al.
Alcohol, Clinical & Experimental Research
|
April 6, 2026
The relationship between alcohol use disorder, measures of cognitive decline, and Alzheimer disease biomarkers in middle aged and older adults
Lisa A Hayibor, Andrey Anokhin, Sherri L Fisher, et al.
Journal of Clinical Psychopharmacology
|
December 21, 2020
Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression
Tahir Rahman, Cory Patrick, Cynthia Ma, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 18, 2024
Hippocampal volumes in UK Biobank are associated with <i>APOE</i> only in older adults
Ariya Chaloemtoem, Vera Thornton, Yoonhoo Chang, et al.
Page
of 7